Wedge Capital Management L L P NC Acquires 222,447 Shares of Ardent Health, Inc. $ARDT

Wedge Capital Management L L P NC boosted its holdings in Ardent Health, Inc. (NYSE:ARDT) by 212.3% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 327,242 shares of the company’s stock after buying an additional 222,447 shares during the quarter. Wedge Capital Management L L P NC owned 0.23% of Ardent Health worth $3,220,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Ardent Health by 103.8% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 14,104 shares of the company’s stock worth $194,000 after acquiring an additional 7,182 shares during the period. Goldman Sachs Group Inc. raised its holdings in shares of Ardent Health by 1,684.9% during the first quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock valued at $10,558,000 after purchasing an additional 724,841 shares during the last quarter. Jane Street Group LLC lifted its position in Ardent Health by 235.1% during the first quarter. Jane Street Group LLC now owns 57,468 shares of the company’s stock valued at $790,000 after purchasing an additional 40,318 shares during the period. Acadian Asset Management LLC lifted its position in Ardent Health by 574.9% during the first quarter. Acadian Asset Management LLC now owns 40,238 shares of the company’s stock valued at $550,000 after purchasing an additional 34,276 shares during the period. Finally, Geode Capital Management LLC lifted its position in Ardent Health by 0.6% during the second quarter. Geode Capital Management LLC now owns 286,848 shares of the company’s stock valued at $3,918,000 after purchasing an additional 1,769 shares during the period.

Insiders Place Their Bets

In related news, CFO Alfred Lumsdaine purchased 10,000 shares of the business’s stock in a transaction on Friday, June 5th. The stock was acquired at an average price of $8.81 per share, with a total value of $88,100.00. Following the completion of the acquisition, the chief financial officer owned 329,183 shares of the company’s stock, valued at approximately $2,900,102.23. This trade represents a 3.13% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 1.90% of the company’s stock.

Ardent Health Stock Down 1.0%

ARDT opened at $10.98 on Friday. The firm’s 50 day simple moving average is $10.16 and its two-hundred day simple moving average is $9.57. The company has a market capitalization of $1.55 billion, a PE ratio of 19.97, a PEG ratio of 3.19 and a beta of 0.70. Ardent Health, Inc. has a 1-year low of $7.71 and a 1-year high of $15.48. The company has a current ratio of 2.12, a quick ratio of 2.00 and a debt-to-equity ratio of 0.62.

Ardent Health (NYSE:ARDT) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.12 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.06). The business had revenue of $1.62 billion for the quarter, compared to the consensus estimate of $1.59 billion. Ardent Health had a net margin of 1.22% and a return on equity of 10.45%. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. As a group, equities analysts forecast that Ardent Health, Inc. will post 0.95 EPS for the current year.

Analyst Upgrades and Downgrades

ARDT has been the subject of several research analyst reports. Weiss Ratings lowered Ardent Health from a “sell (d+)” rating to a “sell (d)” rating in a report on Tuesday. Guggenheim increased their target price on Ardent Health from $13.00 to $14.00 and gave the company a “buy” rating in a report on Thursday, August 6th. Zacks Research cut Ardent Health from a “hold” rating to a “strong sell” rating in a research report on Thursday, August 6th. The Goldman Sachs Group reissued a “neutral” rating and issued a $13.00 target price on shares of Ardent Health in a research report on Thursday, August 6th. Finally, Truist Financial boosted their price target on Ardent Health from $12.00 to $13.00 and gave the company a “buy” rating in a research note on Thursday, August 6th. Seven investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, Ardent Health presently has an average rating of “Hold” and a consensus target price of $13.05.

Ardent Health Company Profile

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.